Skip to search formSkip to main contentSkip to account menu

SDZ NIM 811

Known as: SDZ NIM811, SDZ-NIM-811, SDZ-NIM811 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
SummarySDZ GLC-756, a novel octahydrobenzo[g]quinoline derivative, is equipotent in displacing [3H]SCH23390 from dopamine D1… 
1998
1998
Reactive oxygen-derived free radical species have been implicated in the pathogenesis and pathophysiology of inflammatory lung… 
1998
1998
The disposition of SDZ ENA 713, indicated for the treatment of Alzheimer's disease, was studied in non‐pregnant, pregnant, and… 
Review
1997
Review
1997
Of the many approaches evaluated to treat the symptoms of Alzheimer’s disease (AD), only cholinesterase inhibition has produced… 
1996
1996
This investigation was carried out to evaluate the effect of SDZ GLC-756, a novel dopamine D-1 antagonist and D-2 agonist, on… 
1992
1992
SummaryIn the present study some pharmacological properties of the new muscarinic agonist SDZ ENS 163; (+)-(3S,cis)-3… 
1991
1991
SummaryThe purpose of the present investigation was to study the effects of simultaneous manipulations of central cholinergic… 
1991
1991
To clarify if N-((8-alpha)-2-chloro-6-methylergoline-8-yl)-2,2- dimethylpropanamide (SDZ HDC 912) acts as a dopamine receptor…